ONTTF News and Press, Oxford Nanopore

2026-03-02 17:37:49 ET Oxford Nanopore Technologies plc (ONTTF) Q4 2025 Earnings Call March 2, 2026 5:45 AM EST... Read the full article on Seeking Alpha For further details see: Oxford Nanopore Technologies plc (ONTTF) Q4 2025 Earnings Call Transcript

2026-03-02 15:58:46 ET More on Oxford Nanopore Technologies plc Financial information for Oxford Nanopore Technologies plc Read the full article on Seeking Alpha For further details see: Oxford Nanopore reports FY results

2026-01-12 19:55:57 ET Oxford Nanopore Technologies plc (ONTTF) 44th Annual J.P. Morgan Healthcare Conference January 12, 2026 5:15 PM EST... Read the full article on Seeking Alpha For further details see: Oxford Nanopore Technologies plc (ONTTF) Presents at 44th Annual J.P....

2026-01-06 07:16:59 ET More on Thermo Fisher Scientific, Danaher, etc. Thermo Fisher: Refinding Some Momentum Danaher: Biotech Strength And Cash Generation Reinforce A $250 Fair Value Agilent Technologies, Inc. (A) Presents at Citi Annual Global Healthcare Conference...

2025-12-18 11:20:17 ET Although the shares of long-read sequencing specialist Pacific Biosciences of California, Inc. ( PACB ) (“PacBio”) have done better of late, rising more than 25% since my last "Buy" update in February and outperforming both Illumina ( ILMN ) ...

2025-12-02 12:53:28 ET Oxford Nanopore Technologies plc (ONTTF) Citi Annual Global Healthcare Conference 2025 December 2, 2025 9:45 AM EST... Read the full article on Seeking Alpha For further details see: Oxford Nanopore Technologies plc (ONTTF) Presents at Citi Annual Glob...

2025-09-02 07:45:40 ET Oxford Nanopore Technologies plc (ONTTF) Q2 2025 Earnings Call September 2, 2025 3:30 AM EDT... Read the full article on Seeking Alpha For further details see: Oxford Nanopore Technologies plc (ONTTF) Q2 2025 Earnings Call Transcript

2025-03-05 08:30:00 ET Summary Illumina faces significant challenges from China's "unreliable entity list" and competition from Roche's new SBX technology, impacting its growth prospects. Despite a 37% stock decline since August, Illumina remains a leader in NGS with promising lon...

2025-03-04 15:42:05 ET Oxford Nanopore Technologies plc (ONTTF) Q4 2024 Results Conference Call March 04, 2025 04:30 AM ET Company Participants Gordon Sanghera - Chief Executive Officer Nick Keher - Chief Financial Officer Conference Call Participants Cha...

2025-02-25 22:26:06 ET Summary Pacific Biosciences' Q4'24 results were another disappointment, with revenue and margin misses, and 2025 guidance was notably below expectations. Underlying utilization growth (genetic data generated by PacBio systems) was strong in 2024, showing tha...